While the business case for DE&I across pharma, healthcare, and their allied industries continues to garner support, and organizations have accelerated their efforts, there are still many challenges to measurable, sustainable progress. DE&I leaders cannot become complacent in driving initiatives forward to diversity the workplace and clinical trial participants.

DGE’s 3rd Advancing Diversity, Equity & Inclusion in Pharma & Healthcare Summit helps you take your corporate culture forward, with a strong emphasis on inclusivity, belonging and engagement – all of which will positively impact drug R&D, disease awareness, and clinical trial outcomes. Join us in October to help make sure your organization properly welcomes and cultivates diversity initiatives!